Sunday, November 2, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Scotts Miracle-Gro Faces Critical Earnings Test

Andreas Sommer by Andreas Sommer
November 2, 2025
in Analysis, Cannabis, Earnings
0
Scotts Miracle-Gro Stock
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

This Wednesday brings a pivotal moment for Scotts Miracle-Gro as the company prepares to release its Q4 2025 financial results. Market participants anticipate these figures could significantly influence the stock’s trajectory. Current projections point to a loss of $1.91 per share, with revenue expected to reach approximately $397 million.

Institutional Positioning Shows Dramatic Shifts

Recent filings reveal substantial repositioning among major investors:
– Teacher Retirement System of Texas expanded its stake by a remarkable 1,487%
– FMR LLC increased its position by 5,793%
– Conversely, KAYNE ANDERSON slashed its holdings by 99%

These institutional moves coincide with conflicting insider activity. A company director disposed of 56,633 shares at $63.02 each, totaling $3.5 million in value. Meanwhile, the chief financial officer demonstrated confidence by acquiring 1,790 shares worth approximately $110,000.

Technical Indicators Paint Challenging Picture

The stock’s technical positioning remains under pressure:
* Current trading sits below both the 50-day moving average of $58.58 and the 200-day average of $60.33
* The 52-week range spans from $45.61 to $93.90
* Market sentiment gauges show “Fear” with a reading of 39 on the Fear & Greed Index
* The equity has closed higher on just 10 of the past 30 trading sessions

Should investors sell immediately? Or is it worth buying Scotts Miracle-Gro?

Analyst Outlook Remains Cautious

Market experts maintain restrained expectations. The projected quarterly loss marks a stark reversal from the previous quarter, when Scotts Miracle-Gro surpassed profit forecasts with earnings of $2.59 per share, despite a 1.2% revenue decline.

Recent price target adjustments reflect this cautious stance:
– UBS reduced its target to $62
– Wells Fargo established a $67 target
– The consensus price objective stands near $69

With expectations set low, Wednesday’s earnings announcement could present an opportunity for positive surprise. The convergence of wary analysts, contradictory insider trading patterns, and substantial institutional realignment makes this earnings release a potentially defining moment for the gardening specialist’s stock.

Ad

Scotts Miracle-Gro Stock: Buy or Sell?! New Scotts Miracle-Gro Analysis from November 2 delivers the answer:

The latest Scotts Miracle-Gro figures speak for themselves: Urgent action needed for Scotts Miracle-Gro investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 2.

Scotts Miracle-Gro: Buy or sell? Read more here...

Tags: Scotts Miracle-Gro
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Carter's Stock
Consumer & Luxury

Carter’s Faces Critical Restructuring Amid Deepening Crisis

November 2, 2025
ePlus Stock
Analysis

ePlus Faces Critical Earnings Test Amid Strategic Shift

November 2, 2025
Realty Stock
Analysis

Realty Stock Approaches Critical Earnings Test

November 2, 2025
Next Post
Realty Income Stock

Realty Income's Quarterly Report: A Crucial Test for the Dividend Giant

Opendoor Stock

Opendoor's Bold Move: Rewriting the Rules of Financial Engagement

Coeur Mining Stock

Coeur Mining: Stellar Forecasts Spark Investor Debate

Recommended

American Tower Stock

American Tower Faces Critical Test Ahead of Quarterly Earnings

3 weeks ago
Gladstone Capital Stock

Income Investors Face Setback as Gladstone Capital Reduces Dividend Payout

3 weeks ago
Finance_Fiscal (2)

Analyzing Short Interest in Republic Services Inc NYSE RSG

2 years ago
American Express Stock

American Express Charts Digital Future with Blockchain and Premium Partnerships

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Madison Square Garden Entertainment Faces Critical Earnings Test

Prelude Therapeutics Shares Surge on Analyst Optimism and Upcoming Earnings

A Critical Juncture for Goldman Sachs BDC Investors

High-Yield Opportunity: PennantPark Attracts Income Investors

BioTE Shares Face Critical Test Amid Analyst Downgrades

Definitive Healthcare Faces Pivotal Earnings Test

Trending

Carter's Stock
Consumer & Luxury

Carter’s Faces Critical Restructuring Amid Deepening Crisis

by Dieter Jaworski
November 2, 2025
0

The children's apparel retailer Carter's finds itself navigating its most severe operational challenge in recent memory. Following...

ePlus Stock

ePlus Faces Critical Earnings Test Amid Strategic Shift

November 2, 2025
Realty Stock

Realty Stock Approaches Critical Earnings Test

November 2, 2025
Madison Square Garden Entertainment Stock

Madison Square Garden Entertainment Faces Critical Earnings Test

November 2, 2025
Prelude Therapeutics Inc Stock

Prelude Therapeutics Shares Surge on Analyst Optimism and Upcoming Earnings

November 2, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Carter’s Faces Critical Restructuring Amid Deepening Crisis
  • ePlus Faces Critical Earnings Test Amid Strategic Shift
  • Realty Stock Approaches Critical Earnings Test

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com